654671-77-9N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)OGQPYTJVDPQTBQC-KLQYNRQASA-NSitagliptin Phosphate is the phosphate salt form of sitagliptin, an orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis.
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
white crystalline
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P260, P264+P265, P280, P305+P351+P338, P319, P337+P317, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]
Eye Irrit. 2 (100%)
Skin Irrit. 2 (50%)
Drug Induced Liver Injury Rank (DILIrank 2.0)
Sitagliptin phosphate
vLess-DILI-concern
4
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
SITAGLIPTIN PHOSPHATE
Dipeptidyl Peptidase 4 Inhibitors [MoA]; Dipeptidyl Peptidase 4 Inhibitor [EPC]
Substances which lower blood glucose levels.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
용도Sitagliptin Phosphate Monohydrate is a dipeptidyl peptidase-IV (DPPIV) inhibitor.
불러오는 중…
654671-77-9、654671-78-0DTXSID50904746CHEMBL1201174